Dr. Spasic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
Rm 987
San Francisco, CA 94143Phone+1 415-476-1528
Education & Training
David Geffen School of Medicine at UCLAClass of 2014
Certifications & Licensure
CA State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Clinical and Translational Results from PORTER, a Multi-cohort Phase 1 Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.Matthew D Galsky, Karen A Autio, Christopher R Cabanski, Kristopher Wentzel, Julie N Graff
Clinical Cancer Research. 2025-02-18 - Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, Alexandra Drakaki, Danny N Khalil
The Journal of Experimental Medicine. 2024-10-07 - 152 citationsSotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.Lacey J Padrón, Deena M Maurer, Mark H O'Hara, Eileen M O'Reilly, Robert A Wolff
Nature Medicine. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
